ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.102,15
0,75%
S&P 500
5.930,85
1,09%
US Dollar vs BRL
6,086
0,00%
Bitcoin
94.929,81
-2,34%
Brent Oil
72,72
0,00%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Vericel Corporation (VCEL)

  7. Vericel Corporation (VCEL) Notícias

VCEL

Vericel (VCEL)

Vericel Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VCEL
DataHoraFonteTítuloCódigoCompanhia
05/12/202418:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCELVericel Corporation
04/12/202412:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VCELVericel Corporation
14/11/202408:19Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VCELVericel Corporation
07/11/202410:48Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCELVericel Corporation
07/11/202410:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCELVericel Corporation
07/11/202409:55GlobeNewswire Inc.Vericel Reports Third Quarter 2024 Financial ResultsNASDAQ:VCELVericel Corporation
24/10/202409:30GlobeNewswire Inc.Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024NASDAQ:VCELVericel Corporation
29/08/202410:17GlobeNewswire Inc.Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024NASDAQ:VCELVericel Corporation
26/08/202408:45GlobeNewswire Inc.Vericel Announces FDA Approval and Commercial Availability of MACI ArthroNASDAQ:VCELVericel Corporation
16/08/202417:06Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:VCELVericel Corporation
15/08/202417:05GlobeNewswire Inc.Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal BurnsNASDAQ:VCELVericel Corporation
07/08/202409:30GlobeNewswire Inc.Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024NASDAQ:VCELVericel Corporation
01/08/202408:55GlobeNewswire Inc.Vericel Reports Second Quarter 2024 Financial ResultsNASDAQ:VCELVericel Corporation
22/07/202409:30GlobeNewswire Inc.Vericel Announces Appointment of Karen Mahoney as Chief Human Resources OfficerNASDAQ:VCELVericel Corporation
18/07/202409:30GlobeNewswire Inc.Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024NASDAQ:VCELVericel Corporation
11/06/202409:30GlobeNewswire Inc.Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024NASDAQ:VCELVericel Corporation
22/05/202409:30GlobeNewswire Inc.Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024NASDAQ:VCELVericel Corporation
08/05/202408:55GlobeNewswire Inc.Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial GuidanceNASDAQ:VCELVericel Corporation
24/04/202409:30GlobeNewswire Inc.Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024NASDAQ:VCELVericel Corporation
29/02/202411:04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VCELVericel Corporation
29/02/202409:55GlobeNewswire Inc.Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial GuidanceNASDAQ:VCELVericel Corporation
27/02/202410:30GlobeNewswire Inc.Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024NASDAQ:VCELVericel Corporation
15/02/202410:30GlobeNewswire Inc.Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024NASDAQ:VCELVericel Corporation
14/02/202409:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VCELVericel Corporation
13/02/202408:01Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:VCELVericel Corporation
05/02/202410:30GlobeNewswire Inc.Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024NASDAQ:VCELVericel Corporation
09/01/202409:55GlobeNewswire Inc.Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial ResultsNASDAQ:VCELVericel Corporation
03/01/202410:30GlobeNewswire Inc.Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024NASDAQ:VCELVericel Corporation
08/12/202318:39Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:VCELVericel Corporation
08/11/202309:55GlobeNewswire Inc.Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial GuidanceNASDAQ:VCELVericel Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:VCEL

Seu Histórico Recente

BIT
ESOY
ETFS EUR Daily Hedged So...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados